Ra Pharmaceuticals, Inc. RARX
We take great care to ensure that the data presented and summarized in this overview for Ra Pharmaceuticals, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in RARX
Top Purchases
Top Sells
About RARX
Insider Transactions at RARX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2020
|
Ra Capital Management, L.P. Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,858,260
-100.0%
|
$233,196,480
$48.0 P/Share
|
|
Dec 12
2018
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
1,006,452
+17.16%
|
$15,096,780
$15.5 P/Share
|
|
Feb 14
2018
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
2,500,000
+39.36%
|
$15,000,000
$6.0 P/Share
|
|
Jun 19
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,220
-0.14%
|
$70,840
$22.02 P/Share
|
|
Jun 16
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
53,200
-2.31%
|
$1,117,200
$21.24 P/Share
|
|
Jun 08
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
700
-0.03%
|
$15,400
$22.0 P/Share
|
|
Jun 07
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,840
-0.21%
|
$106,480
$22.11 P/Share
|
|
Jun 06
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,274
-0.31%
|
$160,028
$22.98 P/Share
|
|
Jun 05
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,780
-0.21%
|
$109,940
$23.11 P/Share
|
|
Jun 02
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,867
-0.64%
|
$341,941
$23.47 P/Share
|
|
Jun 01
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,722
-0.46%
|
$246,606
$23.89 P/Share
|
|
May 31
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
35,539
-1.49%
|
$817,397
$23.94 P/Share
|
|
May 26
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,300
-0.22%
|
$132,500
$25.14 P/Share
|
|
May 25
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
53
-0.0%
|
$1,325
$25.0 P/Share
|
|
May 24
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,451
-0.72%
|
$436,275
$25.01 P/Share
|
|
May 18
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,019
-0.37%
|
$225,475
$25.5 P/Share
|
|
May 17
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
22,534
-0.92%
|
$563,350
$25.51 P/Share
|
|
May 16
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,081
-0.82%
|
$522,106
$26.33 P/Share
|
|
Mar 01
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,778
-0.32%
|
$155,560
$20.91 P/Share
|
|
Feb 28
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,847
-0.32%
|
$156,940
$20.86 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders